Australia markets open in 36 minutes

Teva Pharmaceutical Industries Limited (TEVA)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
8.67+0.06 (+0.70%)
At close: 04:00PM EST
8.61 -0.06 (-0.69%)
After hours: 04:33PM EST
Full screen
Trade prices are not sourced from all markets
Previous close8.61
Bid8.70 x 3000
Ask9.05 x 4000
Day's range8.63 - 8.76
52-week range6.78 - 11.34
Avg. volume9,272,773
Market cap9.864B
Beta (5Y monthly)1.27
PE ratio (TTM)N/A
EPS (TTM)-0.56
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend date27 Nov 2017
1y target est9.70

    Hedge funds and C-suites weekly: Bob Iger's return to Disney

    Here is your weekly roundup of the biggest news out of hedge funds and company top brass, all first covered on InvestingPro+.

  • Zacks

    Teva Pharmaceutical (TEVA) Names Richard Francis as New CEO

    Teva Pharmaceutical (TEVA) appoints Richard Francis as the company's new president and chief executive officer, effective from Jan 1, 2023.

  • Business Wire

    Teva Finalizes Nationwide Opioid Settlement Terms

    TEL AVIV, Israel & PARSIPPANY, N.J., November 22, 2022--Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), announced today that the company has finalized the documentation of its proposed nationwide opioid settlement with both the working group of States’ Attorneys General and the Multi-District Litigation Plaintiffs’ Executive Committee. Allergan has also finalized its settlement terms. As announced during the Company’s third quarter earnings ca